GABAergic neurons in the nucleus accumbens core mediate the antidepressant effects of sevoflurane.

[1]  V. Voon,et al.  Bilateral Habenula deep brain stimulation for treatment-resistant depression: clinical findings and electrophysiological features , 2022, Translational Psychiatry.

[2]  Na Sun,et al.  Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis , 2021, Stem cell research & therapy.

[3]  Wugang Hou,et al.  Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway , 2021, CNS neuroscience & therapeutics.

[4]  Huan Gui,et al.  Dopaminergic Projections From the Ventral Tegmental Area to the Nucleus Accumbens Modulate Sevoflurane Anesthesia in Mice , 2021, Frontiers in Cellular Neuroscience.

[5]  Hongxing Zhang,et al.  Behaviors Related to Psychiatric Disorders and Pain Perception in C57BL/6J Mice During Different Phases of Estrous Cycle , 2021, Frontiers in Neuroscience.

[6]  Yan Yan,et al.  Neurons in the Locus Coeruleus Modulate the Hedonic Effects of Sub-Anesthetic Dose of Propofol , 2021, Frontiers in Neuroscience.

[7]  Zhi-Li Huang,et al.  Nucleus accumbens neurons expressing dopamine D1 receptors modulate states of consciousness in sevoflurane anesthesia , 2021, Current Biology.

[8]  Y. Fang,et al.  Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications , 2021, Neuroscience Bulletin.

[9]  Hailan Hu,et al.  Circuits and functions of the lateral habenula in health and in disease , 2020, Nature Reviews Neuroscience.

[10]  P. Yin,et al.  Burden of depression in China, 1990-2017: Findings from the global burden of disease study 2017. , 2020, Journal of affective disorders.

[11]  Runsen Chen,et al.  Sevoflurane augmentation in treatment-resistant depression: a clinical case study , 2020, Therapeutic advances in psychopharmacology.

[12]  V. Voon,et al.  Habenula deep brain stimulation for refractory bipolar disorder , 2019, Brain Stimulation.

[13]  Yilei Zhang,et al.  Sevoflurane Exerts an Anti-depressive Action by Blocking the HMGB1/TLR4 Pathway in Unpredictable Chronic Mild Stress Rats , 2019, Journal of Molecular Neuroscience.

[14]  S. Duan,et al.  Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior , 2019, Nature Medicine.

[15]  S. Kasper,et al.  Circuit Mechanisms of Reward, Anhedonia, and Depression , 2018, The international journal of neuropsychopharmacology.

[16]  S. Tadler,et al.  Emerging evidence for antidepressant actions of anesthetic agents , 2018, Current opinion in anaesthesiology.

[17]  T. Gould,et al.  Mechanisms of ketamine action as an antidepressant , 2018, Molecular Psychiatry.

[18]  Hailan Hu,et al.  Ketamine blocks bursting in the lateral habenula to rapidly relieve depression , 2018, Nature.

[19]  Hailan Hu,et al.  Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression , 2018, Nature.

[20]  L. Vutskits.  General Anesthetics to Treat Major Depressive Disorder: Clinical Relevance and Underlying Mechanisms , 2018, Anesthesia and analgesia.

[21]  D. Nutt,et al.  Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight. , 2017, The lancet. Psychiatry.

[22]  M. Lobo,et al.  Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression , 2017, Biological Psychiatry.

[23]  Carla Nasca,et al.  Mechanisms of stress in the brain , 2015, Nature Neuroscience.

[24]  Alexxai V. Kravitz,et al.  Nucleus Accumbens Medium Spiny Neuron Subtypes Mediate Depression-Related Outcomes to Social Defeat Stress , 2015, Biological Psychiatry.

[25]  J. Krystal,et al.  Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. , 2015, Annual review of medicine.

[26]  S. Floresco.  The nucleus accumbens: an interface between cognition, emotion, and action. , 2015, Annual review of psychology.

[27]  R. Howland,et al.  The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review , 2014, Current neuropharmacology.

[28]  R. Lam,et al.  A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes , 2014, Psychological Medicine.

[29]  L. Vutskits.  CME General Anesthesia : A Gateway to Modulate Synapse Formation and Neural Plasticity ? , 2012 .

[30]  G. Aghajanian,et al.  Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex , 2012, Biological Psychiatry.

[31]  V. Sturm,et al.  Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy , 2012, Neuropsychopharmacology.

[32]  Nanxin Li,et al.  mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.

[33]  Xiong Cao,et al.  Behavioral animal models of depression , 2010, Neuroscience Bulletin.

[34]  Michael X. Cohen,et al.  Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression , 2010, Biological Psychiatry.

[35]  K. Ressler,et al.  Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic , 2007, Nature Neuroscience.

[36]  W. Schlack,et al.  One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. , 2001, British journal of anaesthesia.

[37]  P. Coriat,et al.  A phase III, multicenter, open-label, randomized, comparative study evaluating the effect of sevoflurane versus isoflurane on the maintenance of anesthesia in adult ASA class I, II, and III inpatients. , 1996, Journal of clinical anesthesia.

[38]  P. Anderer,et al.  Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment. , 1995, Neuropsychobiology.

[39]  M. Graf,et al.  Rapid psychotherapeutic effects of anesthesia with isoflurane (ES narcotherapy) in treatment-refractory depressed patients. , 1985, Neuropsychobiology.